A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
An increased prevalence of the metabolic syndrome has been found in patients with systemic lupus erythematosus in recent years.
Cardiovascular Risk Factors
Systemic Lupus Erythematosus
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Association of the Metabolic Syndrome and Systemic Lupus Erythematosus in Taiwan|
- The prevalence of the metabolic syndrome in patients with systemic lupus erythematosus in Taiwan [ Time Frame: One year ] [ Designated as safety issue: Yes ]
Biospecimen Retention: Samples Without DNA
|Study Start Date:||July 2008|
|Study Completion Date:||June 2009|
|Primary Completion Date:||December 2008 (Final data collection date for primary outcome measure)|
Systemic lupus erythematosus
Patients should fulfill the diagnostic criteria of the 1997 American College of Rheumatology for systemic lupus erythematosus
Age- and sex-matched health volunteers will serve as controls.
This study will investigate the prevalence of the metabolic syndrome in patients with SLE in Taiwan. We expect our study will provide further understanding of the association between SLE and metabolic syndrome, which may give direction to prevent late cardiovascular morbidity and mortality in SLE patients.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00982670
|Far Eastern Memorial Hospital|
|Pan-Chiao, Taipei, Taiwan|
|Principal Investigator:||Chun-Chen Yang, MD||Far Eastern Memorial Hospital|